Needham & Company Reiterates Hold Rating on Zogenix (ZGNX) Following Earnings Feb 28, 2022 11:30AM
Needham & Company Downgrades Zogenix, Inc. (ZGNX) to Hold Following Takeover Jan 19, 2022 11:33AM
Zogenix (ZGNX) is a Top Pick, Upcoming Catalysts Will Drive Sales, Current Valuation is an Opportunity - Needham Dec 22, 2021 06:09AM
Zogenix, Inc. (ZGNX) PT Lowered to $40 at Needham & Company, Following Earnings Nov 5, 2021 03:43PM
Needham & Company Reiterates Buy Rating on Zogenix, Inc. (ZGNX) as Fintepla LGS sNDA Submitted Sep 28, 2021 12:00PM


Apr 8, 2021 08:00AM Zogenix to Participate in the 20th Annual Needham Virtual Healthcare Conference
May 6, 2020 07:30AM Zogenix, Inc. (ZGNX) PT Lowered to $50 at Needham & Company on FDA Review Extension
Oct 21, 2019 07:05AM Needham & Company Starts Zogenix, Inc. (ZGNX) at Buy
Apr 9, 2019 09:19AM Pre-Open Stock Movers 04/09: (PHAS) (CERN) (AVYA) Higher; (ZGNX) (ZSAN) (DARE) Lower (more...)
Apr 16, 2014 09:24AM Pre-Open Stock Movers 4/16: (ZLCS) (SODA) (YHOO) Higher; (ASML) (CSX) (TWTR) Lower (more...)
Oct 28, 2013 09:30AM Pre-Open Stock Movers 10/28: (DNDN) (OGXI) (ZGNX) Higher; (SNTA) (CYOU) (RNF) Lower (more...)